<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR40">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Desai</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Beitinjaneh</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Ramdial</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Ali</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Lekakis</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Pereira</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Kimble</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Florou</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Bravo</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Goodman</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Byrnes</surname>
    <given-names>JJ</given-names>
   </name>
   <name>
    <surname>Jimenez</surname>
    <given-names>AM</given-names>
   </name>
   <name>
    <surname>Saneeymehri</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Komanduri</surname>
    <given-names>KV</given-names>
   </name>
  </person-group>
  <article-title>Safety of high-dose melphalan (200â€‰Mg/M2) as conditioning for autologous stem cell transplantation for myeloma in elderly patients</article-title>
  <source>Biol Blood Marrow Transplant</source>
  <year>2017</year>
  <volume>23</volume>
  <fpage>S133</fpage>
  <lpage>S134</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bbmt.2016.12.250</pub-id>
 </element-citation>
</ref>
